NCT00099866View on ClinicalTrials.gov

Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

570

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

DRUG

Metformin Comparator

Trial Locations (1)

Unknown

Novartis investigative Site, Investigative Sites

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY